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Abstract: Malaria is a significant public health problem in more than 100 countries and 
causes an estimated 200 million new infections every year. Despite the significant effort to 
eradicate this dangerous disease, lack of complete knowledge of its physiopathology 
compromises the success in this enterprise. In this paper we review oxidative stress 
mechanisms involved in the disease and discuss the potential benefits of antioxidant 
supplementation as an adjuvant antimalarial strategy. 
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1. Introduction 
According to the World Health Organization (WHO), malaria is a significant public health problem 
in more than 100 countries and causes an estimated 200 million infections each year, with more than 
500 thousand deaths annually. Over 90% of these deaths occur in sub-Saharan Africa, where the 
disease is estimated to kill one child every 30 seconds [1]. In other areas of the world, malaria causes 
substantial morbidity, especially in the rural areas of some countries in Asia and South America. In 
contrast, despite previous elimination in regions like the United States and Western Europe, the 
phenomenon of “imported malaria” introduced by immigrants and travelers, still contributes with 
sporadic cases in these regions [2]. 
In Brazil, a country in which malaria is endemic, the situation is equally alarming. Even with a 
cutback in the number of reports on malaria cases in recent years, the high risk of malaria incidence 
and transmission in the Amazon region persists. According to the Ministry of Health, 99.7% of malaria 
cases are concentrated in the Amazon region. Strengthening of the national malaria control program in 
2000 has resulted in a steady decrease since 2005, according to the Annual Parasitic Incidence in the 
Amazon area. Although the malaria rate has decreased, resistance to drug therapy has increased, 
especially in patients infected with Plasmodium falciparum, responsible for about 20% of the cases in 
this region [3]. 
In fact, current drugs such as chloroquine [4] and artemisinin [5,6], already present resistant strains 
of Plasmodium falciparum. However, factors leading to this resistance are still not well known owing 
to a lack of thorough understanding on the physiopathogenic mechanisms of the disease. 
Several authors have discussed the implications of free radicals through oxidative stress in the 
physiopathogenesis of malaria [7–18]. This involvement may be related to the pathogenic mechanisms 
triggered by the parasite [19], as well as free radical production [20] and antioxidant defenses [21] in 
host cells to abate the infection.  
The role of oxidative stress during malaria infection is still unclear. Some authors suggest a 
protective role, whereas others claim a relation to the physiopathology of the disease [21]. However, 
recent studies suggest that the generation of reactive oxygen and nitrogen species (ROS and RNS) 
associated with oxidative stress, plays a crucial role in the development of systemic complications 
caused by malaria. Malaria infection induces the generation of hydroxyl radicals (OH•) in the liver, 
which most probably is the main reason for the induction of oxidative stress and apoptosis [22]. 
Additionally, Atamna et al. [23] observed that erythrocytes infected with P. falciparum produced OH• 
radicals and H2O2 about twice as much compared to normal erythrocytes. 
A potential source of free radical production in this disease is the host’s hemoglobin molecule, 
since the parasite uses this molecule as a source of amino acids for its own nutrition during the 
erythrocytic stage of the disease, resulting in the liberation of large amounts of circulating heme. By 
having Fe2+-associated groups, these heme groups are able to induce intravascular oxidative stress, 
causing changes in erythrocytes and endothelial cells and facilitating the internalization of the parasite 
in tissues such as the liver and brain [14].  
A free radical species, which appears to be involved in this disease is nitric  
oxide (NO) [7–12,24,25]. However, its role is still controversial. Some researchers claim that cerebral 
malaria is probably an unfortunate consequence of high amounts of NO production to promote the 
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death of the parasites [26,27] while others support the idea that cerebral malaria results from a low 
bioavailability of this compound [28]. 
Additionally, host-parasite interactions are quite complex and promote constant changes in the 
delicate balance between pro-oxidant and antioxidant molecules since the host and parasite are capable 
of producing both. Nevertheless, even anti-malarial drug therapy constitutes a source of oxidation, as 
many drugs such as chloroquine, primaquine and derivatives of artemisinin are inducers of free radical 
production [29–31]. 
This review endeavors to present the oxidative stress mechanisms in malaria as well as discuss the 
potential benefits of antioxidant supplementation therapy as an adjunct to anti-malarial treatment. 
2. Oxidative Alterations in the Host Induced by Plasmodium 
In response to infection caused by Plasmodium parasites, the natural host defense mechanism is 
activated with involvement of phagocytes (macrophages and neutrophils). These, in turn, generate 
large amounts of ROS and RNS, causing an imbalance between the formation of oxidizing species and 
the activity of antioxidants. This imbalance is what triggers oxidative stress, which is an important 
mechanism of human hosts in response to infections and, in the case of malaria, can lead to the death 
of the parasites. 
In vitro studies have demonstrated the ability of oxidative stress to promote the killing of parasites. 
Incubation of Plasmodium yoelii species in the presence of glucose and glucose oxidase generated 
H2O2, a reactive oxygen species, capable of killing the parasite. Likewise, when incubated in the 
presence of xanthine and xanthine oxidase, it generated free radical superoxide (O2
•−) and a subsequent 
burst of other oxidative products, with consequent destruction of parasites [32]. 
Furthermore, oxidative stress markers in infected humans and rats are found in high levels 
compared to uninfected controls [21,22,33–35]. In such cases oxidative stress seems to result from 
increased production of free radicals, a fact suggested by increased malondialdehyde (MDA), an 
important lipid peroxidation marker, and not from a decrease in levels of antioxidants, reinforcing the 
suggestion that oxidative stress is an important mechanism in parasite infection [24].  
Recent studies suggest that oxidative stress can take part in the pathogenesis of thrombocytopenia 
associated to malaria. Erel et al. [36] showed that the number of platelets and the activities of 
antioxidant enzymes—superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px)—in patients 
with vivax malaria were reduced while lipid peroxidation of platelets (estimated by measuring the 
MDA), was elevated in infected individuals, suggesting a negative correlation between platelet count 
and platelet level of lipid peroxidation. These data suggest that oxidative stress occupies an important 
role in the genesis of thrombocytopenia present in malaria through loss of elasticity of membranes and 
by increasing brittleness and causing dysfunction in receptors, resulting in considerable functional 
impairiment of thrombocytes. 
Indeed, the importance of these radical species in the genesis of rheological changes in malaria 
patients has led us to believe that one should avoid iron replacement in infected individuals, despite the 
degree of anemia observed by the erythrocytes count [36,37]. 
Along with the synthesis of radical species, organisms have developed different antioxidant defense 
mechanisms in response to increased oxidative stress. In fact, antioxidant defense is a natural 
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physiological mechanism of organisms against damage caused by free radicals and it depends on the 
consumption of cellular and systemic antioxidant reserves. Endogenous synthesis of these antioxidant 
compounds typically consists of three interdependent systems: enzymatic, small molecules and metal 
chelation, which retards or prevents oxidation of biomolecules. The antioxidant defense system  
also avoids oxidative species generation by scavenging or by free radicals reduction, which by  
self-oxidation form less reactive compounds [38]. 
Although several antioxidant enzymes are important in the defense system, the most important 
include GSH-Px, catalase and SOD. These enzymes act directly on some free radicals, making them 
less reactive. However, they are not able to act on the highly reactive free radicals that are chiefly 
responsible for oxidative pathological processes such as hydroxyl and perhydryl radicals  
or peroxynitrite. 
As a result, our body uses small molecules that reduce the reactivity of various reactive radicals as 
an auxiliary antioxidant defense system. This group contains a large number of molecules, such as 
vitamins A, C and E, beta-carotene, uric acid and reduced glutathione molecule (GSH). In addition, 
our organism has proteins that bind to transition metals preventing them from catalyzing the Fenton 
and Haber-Weiss reactions, important sources of reactive species production. These metal chelators 
include ferritin, transferrin and lactoferrin (chelating iron), ceruloplasmin and albumin (copper 
chelators) and metallothioneins having thiol groups capable of binding several heavy metals [39]. 
Among the antioxidant molecules, the GSH molecule stands out as being the most powerful 
protector of eukaryotic cells in the host defense against oxidative stress, acting upon several different 
mechanisms [40]. In parallel, the secretion of tumor necrosis factor-alpha (TNF-α) appears to induce 
oxidative stress through modulation of GSH metabolism, playing an important role in malaria 
physiopathogenesis. In studies with rats, the administration of TNF-α induced decreased GSH levels, 
whereas in CD4+ and CD8+ splenic T cells, a significant increase occurred in oxidized glutathione 
(GSSG) [41], thus both behaviors suggest oxidative stress increase. Several authors have reported 
decreased GSH in malaria patients [40,42]. 
However, besides GSH, lower levels of various antioxidants are found in malaria patients caused by 
Plasmodium vivax. These are: antioxidant enzymes and glutathione S-transferase (GST) [21,43], 
catalase, GSH-Px, SOD [11,42], NADPH-methemoglobin reductase [11]; heavy metal chelators 
desferrioxamine, salicylaldehyde isonicotinoyl [44] and ferritin [42]; small molecules such as  
vitamins A, E, C [45–47]; the pro-vitamins α- and β-carotene, lycopene, lutein and zeaxanthin [45],  
among others. 
Similarly, Plasmodium falciparum malaria patients presented lower levels of antioxidants, such as 
ascorbate, which correlated with disease severity, in contrast to elevated levels of urate and 
ceruloplasmin [48]. Accordingly, the increase in levels of urate may indicate the presence of  
ischemia-reperfusion syndrome (IRS) responsible for free radical production in ischemic conditions or 
even in hypoxia [49] due to parasite-induced hemolysis and cytoadherence. 
Likewise, decreased GST activity is directly related to the severity of the parasitemia, since the 
production of this enzyme reduces complications of malaria and occurrence of severe malaria [21,43]. 
In this sense, the assessment of GST levels, lipid peroxidation and catalase, may be considered as 
potential biochemical markers of disease severity.  
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In children, all acute phase proteins (APP) are useful markers of the type and severity of 
inflammation in malaria, since all APP, except for α1-antichymotrypsin, were significantly correlated 
with splenomegaly, while α1-acid glycoprotein (AGP) and C-reactive protein (CRP) indicated chronic 
inflammation [50]. Likewise, concentrations of albumin, apolipoprotein A1 (apoA1), transferrin, zinc, 
vitamin A, immunoglobulins G and M, interleukin 10 (IL-10), tumor necrosis factor-alpha (TNF-α) 
and interferon-gamma (IFN-γ) were verified. Children with malaria had decreased levels of apoA1 and 
albumin, but high levels of IL-10 when compared to children without malaria. All antioxidants studied 
showed lower levels in patients with the disease [51]. 
In another study, mice infected with Plasmodium berghei showed significantly increased lactate 
and alanine concentrations in the final stage of cerebral malaria, additionally, glutamine and essential 
amino acids levels were slightly elevated in the brain [52]. 
Mice infected with P. vinckei vinckei exhibit erythrocytic protection against reactive oxygen species 
by the enzymes superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, NADPH 
and NADH-methemoglobin reductase in red blood cells [34]. 
In cultured endothelial cells incubated with heme, an aggravation of oxidative stress mediated by 
polymorphonuclear leukocytes was observed, which may probably be reversed by heme-oxygenase 
and ferritin mRNA induction, additionally to the administration of antioxidants such as catalase, 
reduced glutathione and superoxide dismutase [42].  
Another possibility of damage reversion consists in the administration of iron chelators, which 
inhibits the growth of P. falciparum in vitro, such as hydrophilic desferrioxamine (DFO). Related 
factors to the use of these substances showed greater efficiency of anti-malarial drug action [44].  
Plasmodium berghei infection in mice induces liver injury, increases mRNA expression of 
interleukin-12 (IL-12), protein 40 (p40) as well as IFN-γ, interleukin-4 (IL-4) and IL-10, with 
consequent increase in NO synthesis. Treatment with anti-IL-12 provides an indirect reduction of free 
radical production, thus prolonging survival, reducing liver damage and weight loss, but without 
alteration of the parasitemia [53]. 
A study conducted with 273 children between the ages of 1–10 with acute uncomplicated  
P. falciparum malaria in Kampala, Uganda, verified the antioxidant status in the pathogenesis of the 
disease. Children with acute malaria had low antioxidant plasma concentrations. On the other hand, in 
children with higher plasma lycopene levels, there was fast parasitemia clearance [45]. 
In addition to lycopene, other antioxidant substances are known to act as an adjunct in drug therapy 
such as riboflavin, a reducing agent that acts in the parasite food vacuole and hemozoin formation [54], 
which, as allicin, is an inhibitor of cysteine protease found in garlic extracts and acts by inhibiting 
circumsporozoite protein (CSP) processing, essential for the invasion of host cells [55]. 
Oxidative stress is commonly observed to arise from five sources during disease physio-pathogeny: 
1, Inflammatory process initiated in the host in response to infection; 2, transition metal catalysis, since 
in feeding on hemoglobin, the parasite releases significant amounts of free iron; 3, the occurrence of 
ischemia-reperfusion syndrome, resulting from cytoadherence processes and anemia triggered by 
infection; 4, direct reactive species production by the parasite; and 5, action of antimalarial drugs. 
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2.1. Oxidative Stress as Host Defense Mechanism against Plasmodium Infection 
It has been shown that oxidative stress is related to a protective role in malaria patients, as possible 
agents capable of destroying the Plasmodium. Thus, H2O2 and O2
•− can operate independently as 
cytotoxic agents or form other toxic molecules, including radical OH•, hypochlorous acid (HOCl) and 
peroxynitrite (ONOO−) in the presence of NO [22]. 
The increased production of ROS by phagocytes, as part of the host defense, is a primary event. 
ROS generated by macrophages are known as non-specific effectors molecules in the host’s defense 
arsenal, which can contribute to oxidative damage in the parasite as well as parasitized erythrocytes, 
once ROS are able to diffuse through the membrane of red blood cells [56]. Likewise, neutrophils 
secrete proteolytic enzymes and ROS, which in low concentrations can trigger apoptosis of endothelial 
cells and necrosis in high concentrations [57]. 
In fact, it is generally accepted that ROS, including O2
•− and ONOO−, can destroy the parasite 
intraerythrocytically [35]. Therefore, severe malaria caused by Plasmodium falciparum is associated 
with activation of neutrophils and monocytes, elevated levels of cytokines and endothelial injury. 
Thus, activated neutrophils and their secreted products can exert not only anti-parasitic, but also 
endothelial injury, which can lead to organic failure in severe malaria [57]. 
The inflammatory process mediated by effector immune response mechanisms is required as the 
homeostasis of the organism is modified. However, in some cases, such as in malaria, these 
mechanisms are not sufficient to eliminate some Plasmodium species and to some extent, may act in a 
manner that further harms the host cell. 
With regard to malaria, the immune mechanisms are not fully understood yet, but it is known that 
the cytokine profile, which is proven effective in tackling the infection, is the mechanism that involves 
cellular response by helper T lymphocytes (Th) 1, with prevalence of TNF-α, IFN and IL-12. On the 
other hand, the Th2 profile (IL-4, IL-5, IL-10 and Transforming Growth Factor beta—TGF-β) are 
considered to aggravate severe conditions of the disease. However, there is no consensus on these 
profiles [56,57], because different cellular responses act efficiently in different stages of parasite 
elimination: the first, essential at the initial process of infection, allows the host to mount an adaptive 
immune response against the parasite, but on becoming exaggerated or chronic, may favor severe 
anemia processes; the second promotes the clearance of the initial response (Th1) to be replaced by the 
adaptive action response. Obviously, if such responses are not properly activated, the parasite will tend 
to resist host defense [58].  
Nevertheless, we know the importance of ROS/RNS participation in the parasitemia elimination 
process as the main mechanism through which most anti-malaria drugs act. These substances are also 
known to regulate immune responses by stimulating or inhibiting production of a certain cytokine, 
transcription factor and even regulating cell death processes [59]. 
Apoptosis is a natural process of cell death induced by intracellular mechanisms without the release 
of intracellular contents in the extracellular matrix. Such a mechanism is particularly interesting, since 
toxic substances from intracellular apoptotic cells do not harm surrounding cells, unlike necrosis. 
Cytochrome c, a mitochondrial protein, is among the substances known to regulate this process, which 
under normal conditions, linked to phospholipid (cardiolipin), participates in the electron transport 
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chain [60]. However, under stressful conditions, cardiolipin is oxidized, releasing cytochrome c, which 
upon reaching the cytosol, forms complexes with activating proteins of the apoptotic process. 
The oxidation process of fatty acids, termed lipid peroxidation, appears to originate from the 
cardiolipin oxidation in the apoptosis context. Dey et al. [61] attribute the hydroxyl radical with the 
function of triggering the process in hepatocytes. 
Further to lipid peroxidation, it is known that NO can play a key role in eliminating the parasite. 
According to Jaramil et al. [62], despite the contribution of NO as a free radical in the destruction of 
Plasmodium, too much NO causes immune-suppression and leads to the development of cerebral 
malaria. Some parasitic molecules are well known for inducing NO, but there is a direct contribution 
of malarial pigment—hemozoin, which, associated with the IFN mediator of mRNA synthesis by the 
enzyme nitric oxide synthase (iNOS), is a potent inducer of NO generation in macrophages via 
extracellular signal regulated by kinase (ERK) and nuclear factor κB (NF-κB). It is also known that at 
the hepatic stage, defense mechanisms are strictly related to the production of IFN by Natural Killer 
cells (NK), with subsequent NO synthesis [63]. 
It has also been observed that in addition to inducing NO, hemozoin is responsible for macrophage 
activation through mechanisms partially dependent on NO [15] and, according to Brinkmann et al. [64], 
on other ROS/RNS such as the superoxide radical and hydrogen peroxide. Similarly, increased levels 
of iNOS in human monocytes are not associated with the worsening of malaria in patients infected 
with P. falciparum [65]. 
Syarifah et al. [66] studying mice susceptible and resistant to cerebral malaria infected with 
Plasmodium berghei, observed that the expression of cytokines (except for IL-4 and RANTES) as well 
as the expression of NO tested on mice spleen cells was enhanced in cells of resistant animals when 
compared to cells of susceptible animals. It is important to emphasize the high production of TNF-α in 
resistant mice, suggesting that activation of macrophages is significantly higher in these animals. 
Corroborating these findings, Kumaratilake et al. [67], using radiometric assays that quantify the 
antiplasmodial effect of phagocytes, verified in humans infected by P. falciparum that TNF-α 
increased the release of toxic reactive oxygen intermediates on neutrophils, which contributed to the 
elimination of the parasite. 
Additionally, it has been demonstrated that the free heme can stimulate both neutrophil migration 
and ROS/RNS production by a G protein-coupled receptor, more specifically the inhibitory Gα receptor, 
which in turn activates protein kinase C, increasing the inflammatory response [68] and delaying 
apoptosis [59], thereby most probably contributing to the immune-suppression induced by malaria [69]. 
Among several cytokines already studied, an increase in the Granulocyte-Macrophage  
Colony-Stimulating Factor (GM-CSF) appears to correlate with the reduction of parasitemia and, in 
this context, with oxidative stress. GM-CSF is a cytokine with stimulatory action on granulocytes and 
macrophages and promotes an increase in the number and activity of these cells, acting effectively in 
cellular immunity against malaria. Several studies have shown that previous administration of  
GM-CSF, alone or associated with other factors, protected experimental animals from infection by 
various parasites [70,71]. 
Similarly, animals deficient in GM-CSF synthesis had an impaired immune response against 
parasite infection [72]. There seems to be a relation between GM-CSF and oxidative stress: GM-CSF 
and IL-4 receptors may be modified by lipid peroxidation products originating from hemozoin released 
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by rupture of parasitized erythrocytes, such as 4-hydroxynonenal (4-HNE). GM-CSF and IL-4 are 
stimulators of the differentiation of hemozoin-loaded monocytes in dendritic cells. This differentiation 
can be inhibited by the 4-HNE and play an important role in immune suppression present in  
malaria [73]. 
Moreover, this mechanism appears to be associated with the expression of peroxisome  
proliferator-activated receptor gamma (PPAR-γ) in immature dendritic cells loaded with hemozoin 
following administration of (15) S-hydroxyeicosatetraenoic acid—a PPARγ ligand produced by hemozoin 
via peroxidation induced by the heme—which inhibits the differentiation process of these cells [74]. 
There is also a relationship between GM-CSF and NO, as shown by Kaur et al. [71], demonstrating 
that pre-treatment with GM-CSF and methionine encephalin (TGG) protects mice from malaria. 
However, when animals were pre-treated with inhibitors of inducible form and both forms of NOS, the 
mortality rate of the animals increased significantly, suggesting that the protection exerted by  
GM-CSF/TGG was, at least partially, due to NO. 
2.1.1. The Role of NO in the Physiopathology of Malaria 
NO is one of the smallest and simplest biosynthesized molecules [75]. It is an inorganic, colorless, 
free radical gas, with seven nitrogen and eight oxygen electrons [76] and presents a sometimes 
beneficial, sometimes harmful dubious role in the body [77]. It has been shown to be involved in many 
important biological functions, such as vasodilatation, blood pressure regulation, inflammation and 
unspecific immunity, neuronal plasticity, as well as to act as a neurotransmitter in the brain and 
peripheral nervous system. This molecule is also capable of lysing tumor cells [78,79].  
It is produced from the L-arginine substrate by nitric oxide synthase (NOS). Nitric oxide is 
produced in significant quantities during the inflammatory response by macrophages and other 
immune cells, which express the inducible isoform of nitric oxide synthase (iNOS). Nitric oxide 
produced in these circumstances causes lethal oxidative damage to target cells, such as bacteria and 
other micro-organisms [80]. 
Despite being an important cytotoxic mediator of immune activated cells, capable of destroying 
pathogens and tumor cells, NO is potentially toxic, mainly in situations of oxidative stress, which leads 
to the generation of reactive oxygen intermediates and an antioxidant system deficiency [77]. 
Nitric oxide plays an important role in physiological functions and, consequently, many diseases 
may be related to a high or low NO level in the body. The role of nitric oxide in blood-stage malaria 
remains unknown. 
Many authors believe that NO is not capable of killing parasites at in the blood-stage of malaria. 
They have reached this conclusion by comparing serum nitric oxide levels in Plasmodium infected 
mice and humans against control levels in mice and human individuals. These studies conclude that 
nitrite and nitrate levels (NN—stable metabolites of NO) in infected individuals do not differ from 
control levels, and even with an increased NN serum concentration during the blood-stage of malaria, 
parasitemia is not different compared to control values [26,35,81–87].  
Sobolewski et al. [35] also questioned the role of NO in the progression of malaria parasitemia, 
stating that intraerythrocytic Plasmodia are protected from reactive oxygen species by hemoglobin, 
occurring naturally in high concentrations within red blood cells (RBC), requiring levels of reactive 
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oxygen species that surpass hemoglobin protection. In their experiments, NO was not able to fight the 
parasite until levels close to saturation. Other studies with iNOS−/− knockout mice found parasitemia 
levels similar to that of control animals [82,88]. 
However, some researchers like Stevenson et al. [58] and Böhlke [89] suggest that NO has a 
protective role against blood-stage malaria and claim that NO is an essential factor for malaria 
resolution by P. Falciparum. They believe that elevated serum nitric oxide levels are toxic to the 
parasite [90].  
In our personal experience, despite decreasing parasitemia in infected mice by P. berghei, inhibition 
of NOS enzymes favors the development of severe forms of the disease, notably cerebral malaria, 
suggesting that NO is a protective factor preventing aggravation of the disease [91]. 
The chief answer to this impasse is that NO can act both directly and indirectly on malaria 
resolution. It may have a direct action as a parasiticide explained by the action of peroxynitrite, resulting 
from the reaction of NO with O2
•−. Although indirectly, nitric oxide contributes to parasiticidal activity. 
This can occur through increased immune activity, absence of IL-4, the relationship between NO and 
GM-CSF/PPAR-γ, or the relationship between NO and increased ROS/RNS. 
Nevertheless, we also agree that NO has a parasiticidal role in malaria, since high serum levels of it 
favor parasitemia resolution without harming the host. This gas, previously seen as a toxic agent, is 
considered today as a way to resolve this disease, since it may directly act on the inflammatory process 
and indirectly enable the necessary cytokines to activate the immune system. 
NOS enzymes are dimeric flavoproteins containing tetrahydrobiopterin homologous to cytochrome 
P450. There is a classification type that differentiates enzymes according to their physiological 
function, and names them by inducible NOS (iNOS) and constitutive NOS (cNOS). The other 
classification type for NOS enzymes is based on the type of cell in which they are present. These are 
named: NOS1 (present in the cytosol of neurons) [92], NOS2 (present in immune system  
cells) [93,94], and NOS3 (present in endothelial cells) [95]. 
Studies indicate that NO produced by iNOS activation plays an important role in killing several 
pathogens, including Plasmodium [96]. However, recent studies in animal models have shown that 
NOS deficiency or inhibition is not enough for protection against P. berghei [26,82,86,97] but 
hemozoin induces NO formation via iNOS [20] and the increase in monocyte count may be associated 
with high levels of mRNA of this enzyme [65]. 
In contrast, NO produced by endothelial NOS on all tissues acts as blood flow regulator, causing 
vasodilatation, preventing platelet aggregation and inhibiting adhesion of lymphocytes and monocytes 
to to endothelium [77,79], which prevents local ischemia. These effects are crucial in preventing 
cerebral malaria, and the administration of exogenous NO, or substances that release NO, has been 
investigated as adjunctive treatment for malaria, with great results in improving microcirculation, 
reducing brain inflammation and protecting the blood-brain barrier [24,98–101], thus decreasing 
oxidative stress. Exogenous NO is also indicated in the prophylaxis of lung damage of malaria  
patients [102]. 
Infection with the malaria parasite in the Anopheles stephensi mosquito induces the expression of 
nitric oxide synthase. This induction results in the synthesis of inflammatory levels of NO in the host 
circulation, causing an impact on parasite development. It has also been demonstrated that 
glycosylphosphatidylinositol can induce the expression of NOS [103]. 
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An important fact is that livers from immunized mice express mRNA for iNOS between 12 and  
24 h after the arrival of sporozoites in the liver, and these animals, even when treated with a NOS 
inhibitor, are completely protected against the parasite at the erythrocyte stage of malaria [104]. 
Other studies have correlated the incidence of malaria to changes in the promoters of genes 
encoding the enzymes iNOS and G6PD [105]. 
2.1.2. Hemolysis as an Oxidative Stress Induction Factor in Malaria 
During the erythrocytic phase of malaria, red blood cell lysis and the release of hemozoin occurs, 
which consists primarily of ferriprotoporphyrin IX dimers and monomers (FP) and methemoglobin in 
plasmodial proteins. Hemozoin is able to induce cytokine release (TNF-α and IL-1) through cells of 
the monocyte/macrophages system. Free heme is a powerful free radical generator, which can cause 
serious molecular damage to both host and parasite; the heme group contains Fe2+ atoms that can 
catalyze Fenton and Haber-Weiss reactions, generating free radicals. This is why certain drugs, such as 
chloroquine, have an active mechanism to prevent hemozoin formation, promoting accumulation of 
free heme. Thus, chloroquine increases the availability of intracellular heme by disrupting the plasma 
membrane structure and increasing oxidative stress in Plasmodium. 
As a result of oxidative stress, lipid peroxidation occurs, promoting functional and structural 
changes of the plasma membrane that lead to hemolysis, which has always been linked to increased 
levels of thiobarbituric acid reactive substances (TBARS), markers of lipid peroxidation. The high 
levels of lipid peroxidation products, such as TBARS, have already been seen in erythrocytes 
parasitized by P. falciparum, P. vinckei, P. berghei, and P. chabaudi [56]. 
Hemolysis or extensive cell damage can lead to increased concentrations of free heme, causing 
oxidative stress and inflammation. Whereas heme induces neutrophil chemotaxis, Porto et al. [68] 
reported that several heme analogs are able to induce neutrophil migration in vitro and in vivo, and that 
mesoporphyrins, molecules lacking vinyl groups in their rings, were not chemotactic for neutrophils 
and selectively inhibited heme-induced migration. The authors conclude that heme activates 
neutrophils through chemoattractant signaling and that mesoporphyrins may be important in the 
treatment of inflammatory consequences such as bleeding and hemolytic disorders. 
Additionally, the cellular response to hemozoin entails cytokine release [15,105–107] and 
generation of reactive oxygen species such as NO [106]. Research on oxidative stress induced by 
hemozoin/heme is exciting the scientific community because supports the development of new drugs, 
as is the case with the potential antimalarial [(aryl)arysulfanylmethyl] Pyridine (AASMP) [108].  
2.1.3. Oxidative Stress and the Membrane of Infected-Erythrocyte 
During the development of the blood esquizogeny, P. falciparum trophozoites increase the viscosity 
of red blood cells by causing changes in the parasitized cell surface permitting its adhesion to the 
endothelial wall of capillaries, which seems to be a defense mechanism of the parasite, preventing the 
passage of parasitized red blood cells through the spleen and their consequent destruction [109]. 
However, the increased viscosity of the cells appears to be primarily responsible for the blocking of 
blood vessels, especially of kidney capillaries, pulmonary capillaries and brain capillaries, and cerebral 
malaria is the most common reason for coma and death in infected children [110,111]. 
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Among the changes that take place on the surface of red blood cells is the phenomenon of lipid 
peroxidation. In this sense, the parasitized erythrocytes are known to contain large amounts of 
monohydroxy derivatives of polyenoic fatty acids (OH-PUFA) in their lipids, suggesting the 
occurrence of lipid peroxidation due to the release of heme iron from non-enzymatic breakdown [112]. 
One of the common OH-PUFA found and already described as toxic is the 12- and  
15-hydroxy-arachidonic acid (HETE). It is known that the concentrations of OH-PUFA increase 
according to the evolutionary stage of the parasite. However, low concentrations of HETE were found 
after phagocytosis of parasitized RBCs, suggesting that other lipid peroxidation products also may 
play a key role in this process [112]. 
Additionally, oxidative changes in P. falciparum-infected red blood cells seem to be associated 
with the accelerated aging of these cells and contribute to the development of anemia presented by 
these subjects [10]. The development of anemia can promote changes in the circulatory physiology, 
leading to the existence of moments of hypoxia alternating with the maintenance of tissue oxygenation 
at basal levels, favoring the participation of ischemia and reperfusion syndrome (IRS) responsible for 
an additional production of free radicals [39]. 
Indeed, increased lipid peroxidation and oxidative stress reported in human malaria can affect the 
membrane of infected erythrocytes, also promoting the reduction of the deformity of these cells, which 
has been linked to increased mortality of adults and children with malaria. The deleterious 
consequences of increased cell rigidity include microcirculatory obstruction (exacerbating tissue 
hypoperfusion) and cell stiffness with subsequent removal by the spleen, which increases anemia [11]. 
However, in P. falciparum infections, red blood cells infected by mature trophozoites and schizonts are 
sequestered in the capillaries of various organs, which prevents their removal by the spleen. The adhesion 
of these cells to the vascular endothelium (cytoadherence phenomenon) can be related to a large 
number of antigenic variants encoded on the parasite's surface that bind to endothelial receptors [113]. 
This cytoadherence phenomenon is mediated by parasite proteins expressed via stimulation of the 
var gene on the surface of infected red blood cells, such as P. falciparum erythrocyte membrane 
protein 1 (PfEMP1). The expression of such proteins allows these parasitized erythrocytes to connect 
to different host molecules located in the vascular endothelium, such as intercellular adhesion 
molecule type 1 (ICAM-1), platelet endothelial cell adhesion molecule (PECAM), vascular cell 
adhesion molecule (VECAM), hyaluronic acid, heparin sulfate and others, interrupting blood flow and 
causing the impairment of tissues irrigated by clogged vessels [113,114]. 
Other parasite proteins that promote increased membrane stiffness of infected erythrocytes are 
histidine-rich protein associated with deformity (KAHRP) and 3 erythrocyte membrane protein of  
P. falciparum (PfEMP3). Studies have shown that in the absence of both proteins, membranes showed 
low levels of rigidity, and that KAHRP had a greater effect on the stiffness than PfEMP3, suggesting 
that these parasite proteins contribute to the rigidity of red blood cells [115]. 
2.1.4. Ischemia and Reperfusion Syndrome as Oxidative Stress Induction Factors in Malaria 
IRS occurs in malaria during sequestration of parasitized erythrocytes in certain tissues as a result 
of disrupting large amounts of erythrocytes promoted by Plasmodium during malarial paroxysm and of 
cytoadherence of erythrocytes to blood vessels. 
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In this syndrome, restriction of blood flow leads to O2 concentrations lower than normal [39], 
resulting in the uncoupling of mitochondrial oxidative phosphorylation leading to a decrease in 
adenosine triphosphate (ATP) production. This is followed by the consumption of stored cellular ATP, 
which is further degraded to adenosine diphosphate (ADP) and adenosine monophosphate (AMP) and 
finally to adenosine. Should irrigation be restored at this stage, adenosine may be re-phosphorylated to 
ATP. However, if hypoxia persists, adenosine will be irreversibly metabolized to inosine and 
hypoxanthine. During ischemia, ATP shortage would cause failure of sodium-potassium dependent 
ATPase, with consequent accumulation of intracellular Na+ and extracellular K+. These alterations 
could trigger the occurrence of cellular edema by causing increased osmotic pressure and  
cytoplasmic decompartmentalization. 
The phenomenon of cytoplasmic decompartmentalization can be seen as a cellular distress 
condition, in which ions kept in watertight compartments flood into the cytoplasm, causing activation 
of enzymes that should be inactive, triggering communication processes at the intracellular level, or 
promoting free radical production. In this mechanism, Ca2+ ions and ferrous ions (Fe2+) are quite 
important. The free Ca2+ in the cytosol activates the protease calpain, which in turn promotes the 
breakage of a peptide bond of the enzyme xanthine dehydrogenase (XD), changing its activity to 
xanthine oxidase (XO). 
Unlike XD, XO needs oxygen to convert hypoxanthine into xanthine. Thus, during ischemia three 
crucial phenomena occur with merely preparatory effects: The production of hypoxanthine from ATP, 
the conversion of XD in XO, and cytoplasmic decompartmentalization (which also releases iron from 
ferritin into the cytoplasm).  
On the other hand, with reperfusion, the renewed oxygen supply catalyzes the metabolism of 
hypoxanthine by XO. This reaction leads to the production of xanthine, uric acid, O2
•− and H2O2. It should 
be noted that ROS and RNS production only occurs during reperfusion. In turn with the ROS/RNS 
produced in reperfusion, O2
•− and H2O2 can react together in the presence of iron (Haber-Weiss 
reaction) to yield the OH• radical and trigger the magnification and propagation of oxidative damage. 
3. Oxidative Changes in Plasmodium 
3.1. Production of Reactive Species by the Parasite 
Besides host ROS/RNS production in response to infection, the parasite itself is capable of 
producing free radicals, which in turn interfere with the biochemistry of red blood cells and may 
promote or facilitate the internalization of the parasite in hepatocytes and RBC.  
Despite scarce exploration in the scientific literature, aerobic membrane transport mechanisms are a 
major source of free radical and ROS/RNS generation in Plasmodium. Accordingly, a recent study 
found that the absence of NADPH-oxidase expression, an important enzyme in the synthesis of free 
radicals by macrophages, caused no differences in the progression of parasitemia in knockout mice for 
any of the Plasmodium species tested (P. yoelii, P. chabaudi K562, P. berguei ANKA, P. berguei 
K173 and P. vinckei vinckei). These findings led the authors to believe that free radical production 
increased as a result of infection and not from the respiratory burst of phagocytes, possibly due to 
production by the parasite itself [19]. 
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Another factor that reinforces this possibility lies in the complexity and variety of antioxidant 
mechanisms developed by these parasites. 
3.2. Antioxidant Defense Mechanisms in the Parasite 
Plasmodium parasites are subjected to high levels of oxidative stress during development in host 
cells, so that their ability to defend themselves against this aggression is critical to their survival. As a 
result, these parasites have developed several antioxidant defense mechanisms. 
Studies of gene expression during the erythrocytic phase of infection by Plasmodia have 
determined that at the early stage a continuous cascade of gene expression takes place, and at least five 
different proteins with antioxidant properties are expressed in these conditions [116]. 
Additionally, to compensate for the oxidative stress suffered, Plasmodium reduces its own 
production of reactive oxygen species and adapts new mechanisms to prevent oxidative damage 
arising from the host. The apicoplast is one such mechanisms; it is a symbiotic intracellular organelle 
located near the mitochondria which seems to synthesize lipoic acid, a potent antioxidant used by the 
parasite as a defense. Most probably this organelle was incorporated as an evolutionary adaptation of 
the parasite, since this organelle is also present as a symbiont in red algae [117]. 
Moreover, in most Plasmodium cells, the redox homeostasis seems to be based on the synthesis of 
reduced glutathione and thioredoxin system (Trx)/thioredoxin reductase (TrxR). The reduction of 
oxidized glutathione (GSSG) can be supported by the high proportion of the TrxR/Trx system  
in glutathione reductase-deficient cells, which may be important for certain stages of the  
parasite [11,118].  
The glutathione and thioredoxin redox systems represent two powerful means to detoxify reactive 
oxygen species in Plasmodium falciparum and they are efficient systems to prevent parasite 
development inside the host cells [119]. Additionally, an enzyme peroxiredoxin associated with 
chromatin in P. falciparum has been identified, which makes use of thioredoxin and glutaredoxin as 
reducing agents, thereby conferring protection to the parasite against the oxidative insult imposed by 
the host [120]. 
The TrxR, an enzyme involved in the maintenance of redox homeostasis and antioxidant defense, is 
essential for the erythrocytic stages of P. falciparum [121]. The disruption of the parasite antioxidant 
system is a feasible way of interfering with its development during erythrocytic schizogony [122]. 
Furthermore, glutaredoxin-1, thioredoxin-1 and plasmoredoxin are able to efficiently catalyze 
protein deglutathionylation, a widely distributed important mechanism of posttranslational 
modification of thiol groups with glutathione which functions as a intracellular redox signaling 
regulating device [123]. 
In fact, Campanele [124] found that P. falciparum proteins interact with ferriprotoporphyrin IX, and 
that thioredoxin reductase appears to be much more sensitive to inhibition by FP than glutaredoxin. 
However, the parasite’s glutathione reductase proves to be more resistant to being reduced by FP. 
Mashima et al. [125] has verified that the histidine-rich protein-2 complex from  
Plasmodium falciparum (PfHRP2) connected to ferriprotoporphyrin IX has antioxidant properties 
beneficial to the parasite, which may not have been previously recognized by host antioxidants.  
In neutral pH, PfHRP2 modulates the redox activity of ferriprotoporphyrin IX, protecting ascorbate 
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from degradation induced by FP and transition metals and ensuring release inhibition of intermediates 
of the lipid hydroperoxide metabolism. 
Another important antioxidant molecule produced by Plasmodia is glutathione reductase. 
According to Stocker et al. [34], the activity of glutathione reductase, evaluated by blood GSH levels, 
was enhanced in malaria patients only with high levels of infected RBC, probably indicating that a 
significant portion of the increase in GSH was associated with the production by the parasite itself. 
Kehr et al. [120] identified sites of cellular compartmentalization for this enzyme in Plasmodia. 
Moreover, reduced production of glutathione in Plasmodia is not only involved in maintaining an 
adequate intracellular redox environment protecting cells against oxidative stress, but has also shown 
to be linked to unpolymerized FP degradation, thus implicating an increase in chloroquine resistance. 
In a study by Meierjohann et al. [126], the authors verified possible differences in the GSH metabolism 
regulation of chloroquine-sensitive and chloroquine-resistant species of Plasmodium falciparum, using 
a γ-glutamylcysteine synthetase inhibitor and a glutathione reductase inhibitor. It was observed that  
P. falciparum Dd2 species appeared to be more capable of maintaining intracellular GSH than the  
P. falciparum 3D7 species, showing different susceptibility to oxidative stress. Likewise, resistance of 
P. vinckei vinckei to artemisinin appeared to be mediated by GSH action [127]. 
In Müller’s opinion [128], the Plasmodia defense center comprises superoxide dismutase and 
thioredoxin-dependent peroxidase, which, however, also needs catalase and glutathione peroxidase. 
The vital importance of the thioredoxin redox cycle formed by NADPH, thioredoxin reductase and 
thioredoxin, is essential for P. falciparum survival. The parasite also contains a complete functional 
system and GSH of low molecular weight as important intracellular tioredox protection and as a 
cofactor for the redox activity of glutathione S-transferase and glutaredoxin enzymes. 
Another antioxidant molecule described in these parasites is vitamin B6, an essential cofactor in 
more than 100 enzymatic reactions. Plasmodium falciparum possesses a functional vitamin B6 uptake 
system, which is required as it is subjected to stress. This parasite expresses proteins PdX1 and PdX2, 
essential for the biosynthesis of this vitamin. Both plasmodial proteins act together in glutaminase 
activity. However, in order to be an active cofactor, vitamin B6 needs to be phosphorylated by 
pyridoxine kinase [129]. Therefore, inhibition of vitamin B6 synthesis mechanisms may be a potential 
pharmacological target to be explored. 
4. Oxidative Changes in Vectors 
Another point to be discussed about malaria is the role of Anopheles mosquitoes in the transmission 
of the disease and what instruments these vectors use to restrain the advance of evolutive phases of the 
parasite responsible for the onset of sporozoites, thereby checking a potential correlation with 
oxidative stress and antioxidant defenses. 
It has been a prevailing thought that the development and maintenance of certain Plasmodium 
species in Anopheles mosquitoes is closely linked to vector susceptibility. This way, the evolution of 
the parasite to the sporozoite form must trespass the immunological barrier of the mosquito. Some 
strains of Anopheles gambiae are known to resist the parasitic evolution process mainly by oxidatively 
converting tyrosine to melanin, thereby aggregating it around the parasite. This defense mechanism is 
highly associated with the deficiency of the antioxidant machinery by these strains. For instance, initial 
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steady-state catalase mRNA expression levels were found, but were not able to influence increased 
H2O2 production [130]. 
Great attempts have been made to discover the role of the NO molecule in eliminating the malaria 
parasite. This molecule exerts, at least in the mosquito, a protective role reducing parasitemia. In 
addition, some molecules of the parasite are known to induce NOS, such as glycophosphatidynositol. 
Alternatively, hemozoin contributes to this process [131].  
It has also been proposed that hemozoin causes functional changes in malaria vectors, since the 
mosquito can ingest inordinate amounts of host blood during the acute phase. Akman-Anderson et al. [131] 
demonstrated that hemozoin can also induce gene expression of NOS in A. stephensi and A. gambiae 
cells in vitro and in A. stephensi tissue in vivo. It is also known that the mechanism of NO induction in the 
midgut of mosquito A. stephensis is mediated by NO induction mainly via glycophosphatidynositol, 
which, despite exerting insulin-like signaling, is not insulinomimetric, requiring AKT/PKB and an 
ERK activation [103]. 
Furthermore, GSH is the most abundant antioxidant thiol compound in most cell compartments. 
However, the A. gambiae mosquito lacks the gene to encode the respective sequences of amino acids. 
Nevertheless, the mosquito synthesizes an enzyme that is able to mimic glutathione actions: TrxR, 
more specifically Trx-1 [132]. 
Moreover, vectors have antioxidant molecules to protect cells from oxidative damage as well. 
Wongtrakul et al. [133] identified three isoenzymes for glutathione transferase, an enzyme involved in 
GSH synthesis, in Anopheles cracens, an important malaria vector in Thailand. 
Therefore, by using a specific, and probably efficient, oxidative machine, it is quite possible that 
there are mosquito species resistant to parasite infection, and that this resistance is mediated by 
different patterns of redox response.  
5. Antimalarial Drugs and Oxidative Stress 
Quinine was among the pioneer antimalarial drugs. It is extracted from the Cinchona genus tree or 
shrub bark in the tropical region of South America. Although the active mechanism of quinine is still 
not understood well, and despite being used for over 100 years, it is commonly believed to interfere 
with DNA replication of Plasmodium. Quinine was one of the first antimalarial drugs widely used to 
control the disease, but has fallen into disuse owing to emerging parasite strains resistant to the drug. 
Consequently, its use has been replaced by more effective synthetic drugs derived from the acridine 
and quinoline structure, such as chloroquine and mefloquine, aimed at inhibiting heme polymerase and 
preventing the polymerization of heme to hemozoin, thereby causing oxidative-metabolic effects on 
the parasite, since iron from the heme group can catalyze reactions that generate free radicals [133] 
and primaquine, which destroys the gametocytes of malaria parasites. 
The pharmacological therapy currently used is based on the susceptibility of the genus Plasmodium 
to free radicals and oxidants, as well as the interference or inhibition of a metabolic synthesis pathway 
of a molecule essential to the parasite [134]. 
In fact, several substances used as antimalarials are pro-oxidants, which is why they have 
pharmacological power. This is the case for chloroquine, primaquine, and artemisinin among others. 
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This effect may be due to the drug’s ability to promote direct production of free radicals [135] or by by 
inhibiting molecules with antioxidant activity [136]. 
The Artemisia annua plant (Artemisia) is known to be the most ancient antimalarial treatment, 
having been used in China for over 2000 years. It contains artemisinin, a substance which eliminates 
the blood-stage parasites more rapidly than any other drug and works well against  
Plasmodium falciparum species that are resistant to other drugs. This drug produces free radicals in 
contact with iron, a common metal in the body, especially within erythrocytes [134]. This mechanism is 
extremely effective in the destruction process of parasites and causes minimal adverse effects to the host. 
Treatment with artemisinin can provide rapid recovery and leads to elimination of parasites, but the 
reappearance of parasitemia is frequent, which can be explained by the low half-life elimination time 
of the drug (t1/2 = 2, 6 h) and by the decrease of plasma concentrations after repeated doses [137]. 
Several studies have demonstrated the involvement of oxidative stress in the mechanism of action of 
artemisinin [138–141]. 
In pregnant women with the disease, elevated levels of lipid peroxidation markers and reduced 
ascorbate/glutathione against non-infected pregnant women were noted. In addition, in women treated 
with antimalarial drugs, lipid peroxidation levels were even higher, with a more intense GSH and 
ascorbate decrease than in women not treated with these drugs [142]. 
Also, some associations were tested: association metalloporphyrins/artemisinin [143] and 
antimalarial/oxidizing reagents that act synergistically [144]. It is worth mentioning that 
metalloporphyrins/artemisinin effectively act on strains of P. falciparum resistant to chloroquine. 
Pyrimethamine is another antimalarial drug, which increases the expression of antioxidant enzymes 
and nitric oxide levels in mice infected with P. yoelli, also inducing lipid peroxidation and protein 
carbonylation in these animals [145]. 
Moreover, the parasite’s ability to express antioxidant proteins is suggested to be one of the 
resistance mechanisms to antimalarials, since early transcriptional response of genes involved in 
antioxidant protein expression confers the adaptive capacity to certain antimalarial drugs [146]. 
Other pro-oxidant treatment strategies include alternative therapies with antifungal agents such as 
clotrimazole, based on their ability to inhibit hemo-peroxidase with consequent oxidative stress 
induction [147]. 
6. Potential Benefit of Adjuvant Antioxidant Therapy for Malaria 
Despite the common belief that the ability to induce oxidative stress is a typical active mechanism 
of antimalarial drugs, in recent years several plant extracts and other natural products have been tested 
for their antioxidant properties, thus interfering with the mechanisms of the disease by modulating the 
cellular signaling pathway and not by directly inducing the parasites to death. This approach has 
shown very promising results, with high rates of schizonticide and antiparasitic activity, but with 
minor changes in the host redox balance. Some of the plants tested for this purpose include Piper betle L. 
leaves [148], Anogeissus leiocarpus [149] Nigella sativa seeds [150] and flavonoids from  
Artemisia annua L. [151]. The ability of cocoa fruit to kill malaria parasites is also suggested [152].  
Likewise, Agaricus sylvaticus mushroom, which exhibits high antioxidant capacity [153], has been 
tested in mice infected with P. berghei. It promotes an increase in the total antioxidant capacity of 
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animals and a decrease in lipid peroxidation and nitric oxide markers in lung and brain samples of 
these animals. These biochemical changes were correlated with a significant reduction in the 
parasitemia of animals [17,18]. 
Furthermore, the use of antioxidant supplements can reverse or minimize the oxidative damage to 
hosts caused by the use of antimalarial drugs. The administration of curcumin, an herbal antioxidant 
obtained from Curcuma longa, prevented hepatotoxicity in rats treated with chloroquine [154]. 
Likewise, the administration of glutathione promoted reduced parasitemia and increased survival of 
mice infected with P. berghei [155]. 
7. Conclusions 
The role of oxidative stress in the pathophysiology of malaria is a multifactorial phenomenon and 
represents an important aspect of the intricate and complex host-parasite relationship. The sources of 
oxygen-nitrogen reactive species generation implicated in the disease are: (1) The host’s inflammatory 
response; (2) catalysis of Haber-Weiss and Fenton reactions due to high availability of free iron;  
(3) the occurrence of ischemia and reperfusion syndrome, the fluctuating result in the ability of red 
blood cells being able to transport oxygen during malarial paroxysm and of cytoadherence; (4) direct 
production by parasites; and (5) the action of certain pro-oxidants antimalarial drugs. 
Therefore, the use of antioxidant supplements of synthetic or natural origin may constitute a far 
more effective adjuvant antimalarial strategy that causes less damage to the host. However, further 
research is needed to confirm these suggestions. 
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